Dr. Antonio Giordano, MD,PhD
Claim this profileDana-Farber Cancer Institute
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
PR negative
2Breast Cancer
Stage IV
HER2 negative
ER positive
Affiliated Hospitals
Clinical Trials Antonio Giordano, MD,PhD is currently running
INX-315
for Advanced Cancer
This trial is testing INX-315, a new pill that blocks a protein helping cancer cells grow. It targets patients with advanced cancers who did not respond to other treatments. The drug aims to slow or stop cancer growth by blocking a key protein.
Recruiting1 award Phase 1 & 27 criteria
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
More about Antonio Giordano, MD,PhD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Antonio Giordano, MD,PhD has experience with
- Onvansertib
- Paclitaxel
- Binimetinib
- BET Bromodomain Inhibitor ZEN-3694
- GSK5733584
- INX-315
Breakdown of trials Antonio Giordano, MD,PhD has run
Breast Cancer
Breast cancer
Uterine Tumors
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antonio Giordano, MD,PhD specialize in?
Antonio Giordano, MD,PhD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Antonio Giordano, MD,PhD currently recruiting for clinical trials?
Yes, Antonio Giordano, MD,PhD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Antonio Giordano, MD,PhD has studied deeply?
Yes, Antonio Giordano, MD,PhD has studied treatments such as Onvansertib, Paclitaxel, Binimetinib.
What is the best way to schedule an appointment with Antonio Giordano, MD,PhD?
Apply for one of the trials that Antonio Giordano, MD,PhD is conducting.
What is the office address of Antonio Giordano, MD,PhD?
The office of Antonio Giordano, MD,PhD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.